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Cylophosphamide (CYCL) is a strong anticancer and immuno-
suppressive agent but its urotoxicity presents one of the major 
toxic effects that limit its wide usage particularly in high dose 
regimens.  Therefore,  this  study  aimed  to  investigate  Acacia 
Senegal  gum  exudate,  Gum  Arabic  (GA),  for  its  possible  role 
as a natural, nontoxic agent against CYCL-induced urotoxicity. 
Male Swiss albino rats were exposed to CYCL (150 mg/kg BW, 
once i.p) with or without GA oral supplementation (7.5 g/kg/day 
for  6  days)  through  drinking  water.  Glutathione  (GSH), 
Malondialdehyde (MDA) and Nitric oxide (NO) bladder contents 
were assessed. Responsiveness of the bladder rings to acetylcho-
line  (ACh)  in  vitro,  microscopic  and  macroscopic  features  are 
also investigated. CYCL produced pronounced harmful effects 
on bladder urothelial lining with significant increases in (MDA) 
and NO levels in the tissue homogenates. Bladder-GSH content 
is  dropped  by  over  60%  following  CYCL  injection.  Bladder 
contractility, as measured by its responsiveness to ACh, recorded 
a marked reduction. The isolated bladders exhibited such macro-
scopic changes as severe edema, inflammation and extravasation. 
The bladder weight increased as well. Histological changes were 
evident in the form of severe congestion, petechial hemorrhage 
and chronic inflammatory reaction in the lamina propria accom-
panied with desquamated epithelia. GA, a potential protective 
agent, produced an almost complete reversal of NO induction, 
lipid peroxidation or cellular GSH bladder contents in the GA + 
CYCL-treated group. Likewise, bladder inflammation and edema 
were  reduced.  Bladder  rings  showed  a  remarkable  recovery  in 
their  responsiveness  to  ACh.  Bladder  histological  examination 
showed  a  near  normal  configuration  and  structural  integrity, 
with  a  significant  reduction  in  inflammation  and  disappear-
ance of focal erosions. These remarkable effects of GA may be   
attributed to its ability to neutralize acrolein, the reactive metabo-
lite of CYCL and/or the resultant reactive oxygen metabolites, 
through a scavenging action. GA may limit the cascading events of 
CYCL-induced damage, initiating a cytoprotective effect leading 
to structural and functional recovery of the bladder tissues.
Introduction
Cyclophosphamide  (CYCL)  is  an  established  drug  admin-
istered  for  the  treatment  of  both  malignant  and  nonmalignant 
conditions.  CYCL  is  bioactivated  to  its  reactive  electrophilic 
metabolites through the cellular cytochrome P450 enzyme system, 
resulting in their ongoing production and slow accumulation in 
the plasma, causing severe cytotoxic effects in non-target tissues.1,2 
Phosphoramide mustard and acrolein are the products of CYCL 
hydroxylation in the liver.1 Formation of acrolein, a highly reac-
tive electrophilic α, β-unsaturated aldehyde, is suggested to be the 
underlying  cause  of  the  toxicity  of  oxazaphosphorine  cytotoxic 
agents such as CYCL.3,4 Acrolein has been implicated in the urinary 
bladder toxicity in humans5 as well as in animal model systems.4 
Extensive tissue damage in the lungs as a result of CYCL treat-
ment has also been documented.6,7 The most commonly reported 
CYCL-induced urological cytotoxicity is hemorrhagic cystitis.5,6,8 
In patients receiving doses in excess of 200 mg/kg CYCL, a high 
incidence of hemorrhagic cystitis has been reported.6
Presence  of  the  electrophilic  metabolites  of  CYCL  in  urine 
and their contact with the bladder epithelium is the most likely 
the cause of the CYCL-induced bladder injury. Previous reports 
have suggested acrolein as the causal agent for bladder epithelial 
damage.4,6,9  Other  factors  such  as  cytokines,  cyclooxygenase-2 
(COX-2), and reactive oxygen species with other inflammatory 
mediators may contribute to the pathogenesis of CYCL-induced 
urotoxicity. Nitric oxide (NO) is suggested to play a significant 
role in the urinary tract injury associated with CYCL treatment.10 
Oxidative  stress  damage  manifested  by  a  significant  increase 
in the levels of malondialdehyde (MDA) and inhibition of the 
peroxidase  and  catalase  enzymes8,11-13  presents  another  major 
cause  of  the  tissue  damage.  CYCL-induced  urotoxicity  is  the 
major limiting step in its clinical application despite of its potent 
antitumor activity.2
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Cytotoxic side effects of potentially useful therapeutic agents 
on  the  non-target  tissues  is  a  major  concern  and  has  initiated 
extensive studies to identify chemical substances, natural or other-
wise, helpful in reducing or eliminating the undesirable effects.   
A number of reports have elucidated the protective role of various 
compounds against the cytotoxicity of CYCL. Reactive nucleo-
philic  compounds  such  as  2,6-Dithiopurine  (DTP)  have  been 
shown  to  scavenge  the  electrophilic  toxicants  such  as  acrolein 
resulting  from  CYCL  metabolism.4,15  Steroidal  anti-inflamma-
tory  drugs  like  dexamethasone  reduced  bladder  inflammation 
caused by CYCL.16 Agents such as cysteine, N-acetylcysteine and 
mesna (2-mercaptoethane sulfonate) have been demonstrated to 
control  the  CYCL-induced  bladder  damage.12,17  Besides  these, 
CYCL-induced oxidative stress damage was limited by the use of 
antioxidants such as ascorbic acid and stobadine.11,18 Moreover, 
our group has reported a remarkable protective effect of taurine 
against the CYCL-induced urotoxicity.19
In  the  genre  of  cytoprotective  agents  employed  to  mitigate 
the toxic effects of problem drugs, Gum Arabic (GA), a natural 
proteoglycan exudates from the stems of Acacia senegal, is emerging 
as a potential candidate for investigation. GA is a branched-chain, 
complex  polysaccharide,  either  neutral  or  slightly  acidic,  found 
as a mixed calcium, magnesium and potassium salt of a polysac-
charidic acid or that referred as Arabic gum acid. The backbone 
is composed of 1,3-linked b-D-galactopyranosyl units. The side 
chains  are  composed  of  two  to  five  1,3-linked  b-D-galactopy-
ranosyl  units,  joined  to  the  main  chain  by  1,6-linkages.20-23   
The structural characteristics of the gum arabic have been inves-
tigated  once  again  by  Mahendran  et  al.24  through  monitoring 
the composition and physicochemical properties before and after 
treatment with proteolytic enzyme and various alkaline systems. 
The  results  revealed  that  GA  macromolecules  have  a  compact 
structure. Since, proteolytic enzyme of GA resulted in the arab-
inogalactan-protein  component  (AGP)  with  average  molecular 
mass approximately 2 x 106 Da to degrade, yielding material of 
molecular mass approximately 4 x 105 Da, whereas the bulk of the 
material  corresponding  to  the  protein-deficient  arabinogalactan 
component  with  molecular  mass  4  x  105  remained  unaffected. 
Moreover, The gum arabic sample was deglycosylated by treatment 
with anhydrous hydrogen fluoride and revealed the presence of 
two putative core proteins of approximately 3 x 104 and approxi-
mately 5 x 103 Da, respectively, which correspond to proteins of 
approximately 250 and 45 amino acids in length. The study has 
concluded, therefore, that the enzyme did not fully hydrolyze all 
of the protein present and that the AGP component of gum arabic 
consists of carbohydrate blocks of approximately 4.5 x 104 Da 
linked to a polypeptide chain consistent with the wattle blossom 
structure.
GA, a plant hydrocolloide, is extensively used in pharmaceutical 
and processed food industries as a stabilizing and texture-enhancing 
agent. Arab folk medicine has recognized the usefulness of GA in 
regulating the inflammation of intestinal mucosa and as an external 
soothing agent.23 Recent investigations on the application of GA 
as a cytoprotective agent have demonstrated its usefulness against a 
number of drugs. Oral administration of GA significantly palliated 
carbon tetrachloride induced hepatotoxicity in mice,22 gentamicin 
mediated nephrotoxicity in rats20 and cisplatin induced nephro-
toxicity.21 Scavenging of nitric oxide by GA has been reported to 
limit the acetaminophen induced hepatotoxicity in mice.25 Other 
studies have documented the antioxidant properties of GA in a 
variety of animal model systems.26,27 Moreover, Abd-Allah et al.28 
have reported that GA offers a strong antioxidant and radical scav-
enging activity in vivo and in vitro.
The present investigation is an attempt to elucidate the possible 
protective  effects  of  GA  on  the  urinary  bladder  tissue  damage 
resulting from CYCL treatment in a rat model system. Bladder 
tissue responsiveness to Acetyl-choline (Ach), macroscopic charac-
teristics such as extravasation and edema, biochemical parameters 
and histological changes has been studied to evaluate the protective 
effect of GA on the rat urinary bladder.
Results
Effect of GA on CYCL-induced changes in bladder contrac-
tile  responsiveness  of  isolated  urinary  bladder  rings  to  ACh. 
Sensitivity of the isolated urinary bladder rings to various concen-
trations of acetylcholine (ACh) measured under control conditions 
produced minimum and maximum tension readings between 10-5 
and 10-3 M concentrations (Fig. 1) since higher concentrations 
showed the same maximal response. The average increments in the 
urinary bladder ring tension with ACh concentrations 10-5, 10-4 
and 10-3 M for the control group were 48.5 ± 5.39, 86.8 ± 7.86 
and 91.6 ± 11.11 g tension/g tissue, respectively. Treatment with 
CYCL  significantly  decreased  the  responsiveness  of  the  rings 
to  ACh  as  compared  to  that  of  the  control  group  (p  <  0.05).   
Arabic gum prevents cyclophosphamide-induced cystitis
Figure 1. Effect of Gum Arabic on cyclophosphamide-induced changes in 
the urinary bladder contractile response to different concentrations of ACh. 
Data is presented as Mean ± SEM (g tension/g tissue weight). GA was 
given in a dose of 7.5 g/kg/day for 6 days in drinking water before and 
during the experimental period (24 h) of CYCL that was given in a dose 
of 150 mg/kg i.p. CYCL induced a marked reduction in the contractile 
response, in a dose-response fashion, of the urinary bladder strips to Ach 
while GA significantly reserved this effect. Statistical analysis was done 
using one-way ANOVA followed by Tukey-Kramer as post-ANOVA test. 
*Significant difference from control group was accepted at p < 0.05.Arabic gum prevents cyclophosphamide-induced cystitis
the CYCL-induced loss of responsiveness. The bladder rings in 
the combination (GA + CYCL) group bounced back by 1.6- to 
2.3-fold in their response to ACh exposure as compared to the 
CYCL-treated group indicating a significant protective effect of 
AG on the bladder against the CYCL-induced injury (Fig. 1).
Effect  of  GA  on  CYCL-induced  changes  in  macroscopic 
parameters. Macroscopic observation of the urinary bladder for 
CYCL-induced  tissue  damage  showed  a  significant  increase  in 
the bladder weight as percent of the body weight (Fig. 2). Gross 
vascular  congestion  resulting  in  edema  and  hemorrhage  in  the 
tissues had contributed to a 2.2-fold increase in the bladder weight 
of  the  CYCL-treated  group  over  the  control  readings.  Besides, 
the urothelial lining also exhibited a severe ulceration in this case. 
Oral supplementation of GA alone did not produce any noticeable 
difference in the weight as against the control. However, in the   
GA  +  CYCL-treated  group  a  marked  decrease  in  the  vascular 
congestion could be seen as reflected by a 23% drop in bladder 
weight (edema) as compared to the CYCL-treated group.
Effect of GA on CYCL-induced changes in lipid peroxides and 
glutathione contents. Bladder tissue homogenates of the various 
experimental groups were analyzed for malondialdehyde content 
as an indicator of lipid peroxidation (Fig. 3). A dramatic increase 
in MDA content in the bladder tissues of the CYCL-treated group 
(4.8-fold increase as compared to control and AG treated groups) 
was observed. This condition was equally dramatically reversed by 
AG in the case of the GA + CYCL combination group by bringing 
the MDA content back to the control level. Cellular GSH content 
in the urinary bladder homogenates of the CYCL-treated group, 
likewise, demonstrated a severe depletion (a reduction of 60% over 
the control, Fig. 4). A complete recovery of GSH content in the 
GA + CYCL treated group comparable to control and GA treat-
ment levels indicates the same trend as seen in the case of reversal 
of MDA (Figs. 3 and 4).
Effect of GA on NO content (nitrate/nitrite) in the bladder 
tissues. The bladder tissue content of NO of normal rats was 
0.32  ±  0.1  nmol/g  tissue.  CYCL  administration  induced  a 
marked increase in NO content reaching to about 180% of that 
of the control values (Fig. 5). Gum Arabic or GA + CYCL admin-
istration  revealed  no  significant  changes  from  that  of  control 
values (Fig. 5).
Effect of GA on histological changes in the bladder tissues. 
Histological examinations of the fixed tissue samples from CYCL-
treated group exhibit severe edema and congestion of the urinary 
bladder (Fig. 6B and C) as compared to the control (Fig. 6A). 
Petechial  hemorrhage  and  chronic  inflammatory  reaction  in 
the  lamina  propria  of  the  CYCL-treated  bladder  is  obvious.   
In addition to the presence of proteinacious material in the lumen; 
erythrocytes, desquamative epithelium and plasma cells could also 
be seen (Fig. 6B). Focal erosion of the urinary bladder associated 
with  acute  and  chronic  inflammation  in  the  case  of  CYCL-
treatment  could  be  observed  with  PAS  stain  (Fig.  6C),  where 
edema of the adventitial tissue is also evident. Figure 6D presents a 
histological view of the AG + CYCL treated bladder where almost 
normal configuration and integrity of the tissues is visible. There 
is no sign of inflammation or lesions in this sample as against the 
In the CYCL-treated group the mean increments in response to 
ACh were 15.95 ± 2.49, 42.85 ± 2.97 and 48.3 ± 3.11 g tension/g 
tissue, respectively for the above concentrations. CYCL-treatment 
reduced the bladder response by 50–67% for the range of the 
measured concentrations. Pretreatment of the rats with GA alone 
did not affect the sensitivity in any appreciable fashion; however, 
pre-treatment  with  GA  produced  a  remarkable  recovery  from 
Figure 2. Effect of Gum Arabic on cyclophosphamide induced changes 
in urinary bladder relative weight. Data is presented as Mean ± SEM   
(g tension/g tissue weight). GA was given in a dose of 7.5 g/kg/day 
for 6 days in drinking water before and during the experimental period   
(24 h) of CYCL that was given in a dose of 150 mg/kg i.p. CYCL induced 
a  marked  increase  in  urinary  bladder  relative  weight  while  GA  sig-
nificantly reserved this effect. Statistical analysis was done using one-way 
ANOVA followed by Tukey-Kramer as post-ANOVA test. *Significant dif-
ference from control group, # and from CYCL-treated group was accepted 
at p < 0.05.
Figure 3. Effect of Gum Arabic and/or cyclophosphamide on the lipid 
peroxide content in rat urinary bladder homogenates. Data is presented 
as Mean ± SEM (g tension/g tissue weight). GA was given in a dose 
of 7.5 g/kg/day for 6 days in drinking water before and during the 
experimental period (24 h) of CYCL that was given in a dose of 150 mg/
kg i.p. CYCL induced a marked increase in urinary bladder MDA content 
while GA significantly prevented this effect. Statistical analysis was done 
using one-way ANOVA followed by Tukey-Kramer as post-ANOVA test. 
*Significant difference from control group, # and from CYCL-treated group 
was accepted at p < 0.05.
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GA probably acts primarily by neutralizing the ROS and relieving 
the urothelium from the oxidative stress to a large extent, if not 
completely. This in turn would result in a comparable reduction 
CYCL-treated sample. GA treatment by itself did not produce any 
effect on the structural integrity of the bladder.
Discussion
Results of this study have once again conclusively established 
the adverse effects of CYCL on non-target tissues with particular 
reference to the hemorrhagic cystitis of the urinary bladder in an 
animal  model  system.  CYCL-induced  changes  observed  in  the 
biochemical  parameters  are  translated  into  a  visible  structural 
damage. Loss of bladder ring responsiveness to ACh and severe 
edema as reflected by the increased weight due to CYCL treatment, 
indicates gross changes in the structural integrity of the bladder. 
The underlying biochemical changes at the cellular level in terms 
of increased lipid peroxidation led to the macroscopic effects on 
the bladder epithelial lining. The argument that acrolein, an elec-
tophilic reactive metabolite of CYCL produces enormous oxidative 
stress on the target tissues coupled with other observations on the 
production of similar free radicals such as NO3,7,11,14 lend support 
to the observations of necrotic changes in the tissues. Since acrolein 
is not known to exist in the free form for extended periods, it is 
suggested that an acrolein metabolite or its conjugate may elicit the 
observed effects.8,29,30 The extent of the damage would be a func-
tion of both the concentration of the reactive species of the drug 
and the exposure time.
Increased lipid peroxidation (MDA) and decreased sulfhydryl 
(GSH)  along  with  the  increased  NO  bladder  contents,  in  the 
present  work,  point  to  a  greatly  enhanced  potential  for  oxida-
tive stress on the urothelial lining. Ability of acrolein to deprive 
the cell of its natural defense (GSH) against the reactive oxygen 
species31,32 or conjugates of acrolein directly inducing the forma-
tion of oxygen radicals.33 This support the suggestion that the 
outer membrane blebbing as a result of structural damage to the 
membranes34,35 could be an important cause of the compromised 
urothelial  integrity  as  shown  in  our  results.  Gross  histological 
changes manifested as severe inflammation and focal erosions of 
the bladder resulting from the urothelial cytotoxicity may therefore 
be associated with a corresponding loss in the bladder contractility 
(over 50%). CYCL-induced bladder cystitis, therefore, appears to 
be a result of reactive oxygen species (ROS) overload or NO induc-
tion in the system36,37 triggering a cascade of events beginning 
with the membrane damage.
Several studies have documented the palliative effects of a range 
of  substances  on  the  CYCL-induced  effects.12,13,15,19  GA  has 
been shown to limit harmful side effects of several drugs previ-
ously.19-24 Our findings demonstrate the potential of Gum Arabic 
as  a  protective  agent  against  the  deleterious  effects  of  CYCL.   
While on the one hand GA revealed a significant recovery in the 
bladder response to ACh and a reduction in the tissue edema, on 
the other hand it almost completely reversed the trends of oxida-
tive damage to the tissues. Histological observations concur with 
these findings, where a near normal structural configuration of the 
bladder tissues is demonstrated upon GA supplementation.
GA has been demonstrated as an effective scavenger of ROS in 
several studies.20,22,24 Observations on dose dependent scavenging 
of superoxide radicals in vitro by GA19 and its high affinity to 
free radicals38,39 lend additional support to our suggestion that 
Figure 4. Effect of Gum Arabic and/or cyclophosphamide on the glu-
tathione content in rat urinary bladder homogenates. Data is presented 
as Mean ± SEM (g tension/g tissue weight). GA was given in a dose of 
7.5 g/kg/day for 6 days in drinking water before and during the experi-
mental period (24 h) of CYCL that was given in a dose of 150 mg/kg 
i.p. CYCL induced a marked deplesion in urinary bladder GSH content 
while GA significantly restored GSH level. Statistical analysis was done 
using one-way ANOVA followed by Tukey-Kramer as post-ANOVA test. 
*Significant difference from control group, # and from CYCL-treated group 
was accepted at p < 0.05.
Figure 5. Effect of Gum Arabic and/or cyclophosphamide on the (NO) 
nitric oxide content in rat urinary bladder homogenates. Data is presented 
as Mean ± SEM (g tension/g tissue weight). GA was given in a dose of 
7.5 g/kg/day for 6 days in drinking water before and during the experi-
mental period (24 h) of CYCL that was given in a dose of 150 mg/kg i.p. 
CYCL induced a marked increase in urinary bladder NO content while 
GA  significantly  prevented  its  induction.  Statistical  analysis  was  done 
using one-way ANOVA followed by Tukey-Kramer as post-ANOVA test. 
*Significant difference from control group, # and from CYCL-treated group 
was accepted at p < 0.05.Arabic gum prevents cyclophosphamide-induced cystitis
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when  given  orally  by  rats  and  guinea-pigs  and  by  humans.41 
Moreover,  when  GA  administered  by  humans  it  is  excreted  in 
urine by 5–32% of the administered dose as reported by Johnson 
and Newman.42 Experimental and clinical studies are conducted 
to GA in toxicological monograph by WHO, Food additives series 
17 as a study to test for its use as a food additive. GA was evalu-
ated for acceptance for daily intake for man by the joint of FAO/
WHO expert committee on food additive in 1969 that issued in 
1970. GA showed many systemic effects following oral admin- 
istration  in  experimental  animals  and  in  humans  as  shown  by 
Booth et al.43 and Bachman and Zbinden.44 These data support 
the idea that GA may interact with ROS and/or acrolin in the 
urinary bladder in order to limit their damaging effects but the 
exact nature of its mode of action and conditions leading to its 
optimum effect need to be investigated in future studies particu-
larly its effect on the NO synthase activity.
In  summary,  we  conclude  that  Gum  Arabic,  a  natural   
proteoglycan  with  known  uses  in  the  pharmaceutical  and  food 
industries is a potential candidate for a natural cytoprotective agent 
in  the  bladder  inflammation  and  associated  with  a  significant 
decrease in NO content, an inflammatory mediator, with improv-
ment of histological changes. Prevention of edema and a controlled 
petechial hemorrhage are bound to be reflected positively in the 
contractile efficiency of the bladder, especially when the loss of 
responsiveness is thought to be due to inflammation and edema. 
Our results clearly demonstrate a conspicuous relationship between 
the GA mediated reductions in the CYCL-induced lipid peroxida-
tion,  decreased  edema  and  petechial  hemorrhage  and  a  visibly 
improved  histological  profile  with  a  significant  restoration  of 
bladder contractility. Scavenging of the ROS and NO to limit the 
oxidative damage to the cell membranes appears to be the first line 
of action for GA in this case, which follows through with enhanced 
structural integrity resulting ultimately in a significant recovery of 
the bladder functionality. GA’s efficiency as a potent cytoprotective 
agent may depend both on its qualitative and quantitative attri-
butes and accessibility to the target tissues such as the intestine and 
kidney.23 GA is absorbed from GIT following oral administration 
when it is given up to 10% of the diet.40 It is completely digested 
Figure 6. (A) Urinary bladder section from control animal showing a normal mucosa (arrow 1) and muscular coat with fluid in the lumen (arrow 2) 
(H&E stain X100). (B) Urinary bladder section from CYCL-treated animal showing edema, congestion (arrow 1), petechial hemorrhage (arrow 2) and 
inflammation in the lamina propria (arrow 3) with protein aqueous material into the lumen as well as a desquamative epithelium (arrow 4) (H&E stain 
X200). (C) Urinary bladder section from CYCL-treated animal showing edema, congestion, polymorphonuclear leukocytes and occasional erythroctes 
(arrow 1), lymphocytes (arrow 2) and plasma cell (arrow 3) infiltration with acute and chronic inflammation (PSA stain X400). (D) Urinary bladder sec-
tion from GA followed by CYCL-treated animal showing mild residual nonspecific inflammation with almost normal structure (H&E stain X200). GA was 
given in a dose of 7.5 g/kg/day for 6 days in drinking water before and during the experimental period (24 h) of CYCL that was given in a dose of   
150 mg/kg i.p. CYCL induced marked histological changes in rat urinary bladder that were almost completely prevented by GA.Arabic gum prevents cyclophosphamide-induced cystitis
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centrifuged at 1,000 g for 10 min. The absorbance of the superna-
tant was measured photometrical at 532 nm and concentrations, 
expressed as nmol malondialdehyde (MDA)/g tissue, were deter-
mined  against  a  standard  curve  of  1,1,3,3,tetraethoxypropane 
(Sigma chemical CO, St. Louis, MO).
Determination  of  GSH  content  in  urinary  bladder  tissue. 
Tissue  levels  of  acid-soluble  thiols,  mainly  reduced  glutathione 
(GSH), were determined colorimetrically at 412 nm.47 Briefly, 0.5 
ml of previously prepared homogenate was added to 0.5 ml of 5% 
trichloroacetic acid and after centrifugation at 750 g for 5 min., 
the supernatant (200 μl) was added to a tube containing 1,750 μl 
of 0.1 M Potassium phosphate buffer, pH 8) and 50 μl DTNB 
reagent. The tubes were mixed and the developed yellow color was 
measured against standard curve of reduced glutathione. Protein 
thilos (protein-SH) were expressed as μmol/g tissue.
Determination  of  nitric  oxide,  NO,  (as  nitrate/nitrite)  in 
bladder  homogenates.48  From  the  previously  prepared  bladder 
homogenates, 0.5 ml was added to 0.5 ml of absolute ethanol then 
centrifuged at 4,000 rpm for 10 min. Then to 300 μl of the super-
natant 300 μl of vanadium chloride (VCl3, 0.8% in 1 M HCl) 
was added. Then 300 μl of a mixture of Griess 1 and 2 reagents 
1:1, and 100 μl of their solvents were added. Griess 1 reagent is 
composed of N-(1-naphthyl)-ethylenediamine (NEDD, 0.1% in 
distilled water) and Griess 2 is composed of sulfanilamide, 2% in 
5% HCl. The mixture was left at room temperature 30–35 min 
then the color was measured spectrophotometrically at 540 against 
blank. Concentrations of NO were determined from a standard 
curve of different concentration of sodium nitrite. NO equivalent 
concentrations were calculated as nmol/g tissue.
Preparation of the urinary bladder rings. After animals had 
been sacrificed, the lower abdomen was opened and the bladder 
exposed. The connective tissue and accompanying blood vessels 
were cut away and the bladder was cut into rings and placed in 
warm physiological salt solution (PSS). The composition of the 
PSS31 (in g/L): NaCl, 6.9; Na HCO3, 2.1; KCl, 0.35; MgSO4, 
0.15; KH2PO4, 0.16; CaCl2, 0.28 and glucose, 2.0. Rings were 
mounted  horizontally  between  a  clamp  and  a  force  transducer 
for measurement of isometric tension using a Statham transducer 
(Gould  Instrument,  Cleveland,  OH)  in  an  organ  bath  filled 
with 10 ml of the PSS at a temperature of 37°C and gassed with 
95%O2–5% CO2.
Rings were allowed to equilibrate for 30 min prior to experi-
ment under a resting load of 1 g.49 During this time, the bath 
solution was replaced every 5 min. Isometric tension was recorded 
by means of a Stathman transducer connected to a physiograph 
(Narco Bio-system, Houston, TX).
A  concentration-response  curve  to  acetylcholine  (ACh)  was 
constructed. Rings were exposed to different concentrations of Ach, 
ranging from 10-8 to 10-2 M, in a non-cumulative manner. Exposure 
to a dose of ACh was maintained until the maximal response to that 
concentration was reached. The rings were then washed repeatedly 
with several changes of PSS and allowed to return to baseline before 
the addition of the next ACh concentration.
Histopathological  examination.  Urinary  bladders  were 
collected,  as  detailed  above,  and  fixed  in  10%  formalin  in   
and that it primarily acts by mitigating the oxidative stress in the 
CYCL-induced urinary bladder cystitis in rats.
Materials and Methods
Chemicals.  Cyclophosphamide  (CYCL)  (Endoxan-Asta) 
was  purchased  from  ASTA  Medica  AG,  (Frankfurt  am  Main, 
Germany).  GA  was  purchased  from  Riedel-deHaen  (D-3010 
Seelze, Germany). Thiobarbituric acid (TBA) was a product of 
Fluka (Buchs, Switzerland). All the remaining chemicals were of 
the highest analytical grade commercially available.
Animals.  Male  Swiss  albino  rats,  weighing  200–250  g  were 
obtained  from  the  Experimental  Animal  Care  Center,  College 
of Pharmacy, King Saud University, Riyadh, KSA. Animals were 
maintained under standard conditions of temperature (24 ± 1°C) 
and 55 ± 5% relative humidity with regular 12 h light: 12 h dark 
cycle and allowed free access to standard laboratory food (Purina 
Chow, St. Louis, MO) and water.
Experimental protocol. Rats were randomly divided into four 
equal groups of 24 animals each. From each group six animals 
were used for bladder ring preparation and 18 animals for the 
biochemical analysis. The first group (control) rats were injected 
intraperitoneally with saline equal to the volume of the test solu-
tion. The second group received GA (7.5 gm/kg/day) alone in 
drinking water for 6 days, this dose has been adopted and pre-
evaluated by previous studies.25-27 In the third experimental group, 
urinary bladder injury was induced by injecting animals with CYCL 
intraperitoneally at a dose of 150 mg/kg body weight and urinary 
bladder was examined 24 h later. This dose was chosen since it 
had  been  shown  to  produce  severe  urinary  bladder  toxicity.45   
The fourth group received AG (7.5 gm/kg/day, in drinking water 
for  6  days)  then  CYCL  was  injected.  Gum  Arabic  treatment 
was maintained until the end of the experimental period (24 h 
post-CYCL treatment). The experimental period of 24 hours was 
chosen based on previous studies19,28 which demonstrated that 
CYCL produced the maximum bladder injury during this period.
Following  light  ether  anesthesia,  the  rats  were  sacrificed  by 
cervical dislocation and the urinary bladders were quickly isolated, 
washed with saline, blotted dry on filter paper, examined macro-
scopically for detection of extravasations, congestion and weighted 
for detection of edema and then 10% (w/v) homogenates of each 
sample was made from three pooled urinary bladders in ice cold 
saline using homogenizer (VWR Scientific, Danbury, CT). Due 
to the elasticity of the urinary bladder tissue, homogenization was 
run out, on ice, with different speeds until a homogenous tissue 
homogenate was obtained.
Determination of lipid peroxides in urinary bladder homo-
genates.  Tissue  levels  of  lipid  peroxides  were  determined  as 
thiobarbituric acid-reactive (TBARS) substances.46 Tissue homoge-
nates were prepared as mentioned above, then 0.1 ml homogenate 
was added to a tube containing 1.5 ml acetic acid (20%, pH 3.5), 
0.2 ml sodium dodecyl-sulphate (SDS; 8.1%), 1.5 ml TBA (0.8%) 
and  0.7  ml  water;  blanks  were  prepared  by  addition  of  water 
instead of homogenate. The tubes were mixed and incubated in 
a water path at 95°C for 60 min using glass balls as condensers. 
Then,  all  the  tubes  were  cooled  to  the  room  temperature  and Arabic gum prevents cyclophosphamide-induced cystitis
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Agric Food Chem 2008; 56:9269-76.
  25.  Gamal El-din AM, Mostafa AM, Al-Shabanah OA, Al-Bekairi AM, Nagi MN. Protective 
effect of arabic gum against acetaminophen-induced hepatotoxicity in mice. Pharmacol 
Res 2003; 48:631-5.
  26.  Rehman KU, Codipilly CN, Wapnir RA. Modulation of small intestinal nitric oxide 
synthase by gum arabic. Exp Biol Med 2004; 229:895-901.
  27.  Ali BH. Does gum arabic have an antioxidant action in rat kidney? Ren Fail 2004; 26:1-3.
  28.  Abd-Allah AR, Al-Majed AA, Mostafa AM, Al-Shabanah OA, Din AG, Nagi MN. 
Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a 
possible mechanism of protection. J Biochem Mol Toxicol 2002; 16:254-9.
  29.  Ramu K, Fraiser LH, Mamiya B, Ahmed T, Kehrer JP. Acrolein mercapturates: synthesis, 
characterization and assessment of their role in the bladder toxicity of cyclophosphamide. 
Chem Res Toxicol 1995; 8:515-24.
  30.  Ramu K, Perry CS, Ahmed T, Pakenham G, Kehrer JP. Studies on the basis for the toxic-
ity of acrolein mercapturates. Toxicol Appl Pharmacol 1996; 140:487-98.
  31.  Arumugam N, Sivakumar V, Thanislass J, Pillai KS, Devaraj SN, Devaraj H. Acute pulmo-
nary toxicity of acrolein in rats-underlying mechanism. Toxicol Lett 1999; 104:189-94.
  32.  Arumugam N, Thanislass J, Ragunath K, Niranjali Devaraj S, Devaraj H. Acrolein-
induced  toxicicy—defective  mitochondrial  function  as  a  possible  mechanism.  Arch 
Environ Contam Toxicol 1999; 36:373-6.
  33.  Adams JD Jr, Klaidman LK. Acrolein-induced oxygen radical formation. Free Radic Biol 
Med 1993; 15:187-93.
  34.  Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, et al. Effect of com-
bined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosph-
amide-induced programmed cell death of apoptosis in human myeloid leukemia cells. 
Exp Hematol 1993; 21:1640-7.
  35.  Hengstler JG, Hengst A, Fuchs J, Tanner B, Phol J, Oesch F. Induction of DNA cross-
links and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 
2B1. Mutat Res 1997; 373:215-23.
  36.  Inci K, Ismailoglu UB, Sahin A, Sungur A, Sahin-Erdemli I. The effect of inflamma-
tion on rat urinary bladder-dependent relaxation in coaxial bioassay system. Naunyn 
Schmiedebergs Arch Pharmacol 2003; 367:457-552.
  37.  Manesh C, Kuttan G. Alleviation of cyclophosphamide-induced urotoxicity by naturally 
occurring sulphur compounds. J Exp Clin Cancer Res 2002; 21:509-17.
  38.  Oter S, Korkmaz A, Oztas E, Yildirim I, Topal T, Bikgic H. Inducible nitric oxide 
synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats. Ureol Res 
2004; 32:185-9.
  39.  Rehman K, Wingertzahn MA, Harper RG, Wapnir RA. Proabsorptive action of gum 
Arabic: regulation of nitric oxide metabolism in the basolateral potassium channel of the 
small intestine. J Ped Gast Nut 2001; 32:529-33.
  40.  O’Dell BL, Morris ER, Pickett EE, Hogan AG. Diet composition and mineral balance 
in guinea pigs. J Nutrition 1957; 63:65-77.
  41.  Shue GM, Douglass CD, Friedman I. Nutritional studies of complex carbohydrates. 
Federation proceedings 1962; 21:91-5.
  42.  Johnson JB, Newman LH. Intravenous injection of acacia. Arch Intern Med 1945; 
76:167-71.
  43.  Booth AN, Elvehjem CA, Hart EB. The importance of bulk in nutrition of guinea pig. 
J Nutr 1949; 37:263-8.
  44.  Bachmann E, Zbinden G. Biochemical effects of chronically administered suspended 
agents on mitochondrial metabolism and hepatic mixed function oxidase in rats, mice 
and hamster. Arch Toxicol Suppl 1978; 1:183-7.
  45.  Xu X, Malave A. Protective effect of Berberine on cyclophosphamide hemorrhagic cysti-
tis in rats. Pharmacol Toxicol 2001; 88:232-7.
  46.  Ohkawa H, Ohish N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric 
acid. Anal Biochem 1979; 95:351-8.
  47.  Ellman GL. Tissue sulfahydryl groups. Arch Biochem Biophys 1959; 82:70-7.
  48.  Ozawa H, Chancellor MB, Jung SY, Yokoyama T, Fraser MO, Yu Y, et al. Effect of 
intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol 1999; 
162:2211-6.
  49.  Mostafa AM, Nagi MN, Al-Shabanah OA, El-Kashef HA. Effect of amino-guanidine 
and melatonin on the response of isolated urinary bladder to acetylcholine in normal 
and diabetic rats. Med Sci Res 2000; 28:33-7.
phosphate buffer saline, (pH 0.7) for 24 h at room temperature. 
Then, tissues were embedded in paraffin wax and sections were cut 
at 5 μm thickness and stained with haematoxylin-eosin or periodic 
acid-Schiff (PAS) stains using routine procedures. A histopatholo-
gist,  who  was  unaware  of  the  treatments,  examined  the  coded 
slides using a light microscope and recorded and photographed the 
histopathological lesions.
Statistical  analysis.  Data  are  expressed  as  (means  ±  SEM). 
Statistical comparison between different groups were performed 
using one way analysis of variance (ANOVA) followed by Tukey-
Kramer  multiple  comparisons  test  to  judge  difference  between 
groups. Significance was accepted at p < 0.05.
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